| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $450.9M | +17.0% |
| Cost of Revenue | $153.1M | +16.2% |
| Gross Profit | $297.8M | +17.4% |
| R&D Expense | $45.7M | +17.2% |
| SG&A Expense | $67.3M | +9.8% |
| Operating Income | $71.2M | +29.2% |
| Pre-tax Income | $71.3M | +33.2% |
| Income Tax | $16.2M | +81.0% |
| Net Income | $55.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $162.9M | -21.5% |
| Short-term Investments | $51.4M | +3.3% |
| Accounts Receivable | $39.4M | +14.1% |
| Current Assets | $322.8M | -8.4% |
| Total Assets | $672.9M | +9.3% |
| Current Liabilities | $110.6M | +7.6% |
| Total Liabilities | $135.8M | +3.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $100.1M | -11.4% |
| Capital Expenditures | $19.9M | +1.5% |
| Investing Cash Flow | -$112.8M | -141.5% |
| Financing Cash Flow | -$31.6M | -278.3% |
| Free Cash Flow | $80.2M | -14.1% |
| +23.6% |
| EPS (Basic) | $1.53 | +23.4% |
| EPS (Diluted) | $1.49 | +23.1% |
| Stockholders' Equity |
| $537.1M |
| +10.9% |